Publication:
Challenges for gene therapy in the financial sustainability of health systems: a scoping review

Simple item page
dc.contributor.authorOssandon, Hugo
dc.contributor.authorArmijo, Nicolás
dc.contributor.authorVargas, Constanza
dc.contributor.authorRepetto, Gabriela
dc.contributor.authorEspinoza, Manuel
dc.date.accessioned2024-07-03T16:33:54Z
dc.date.available2024-07-03T16:33:54Z
dc.date.issued2024
dc.description.abstractAim: To review the available evidence about the strategies implemented or proposed for coverage or reimbursement for currently approved gene therapies. Methods: A scoping review was conducted to analyze the evidence published during the years 2016 to 2023. The main search criteria were coverage or reimbursement of gene therapy by healthcare systems. The eligible articles were those that described or proposed a financing model used to provide coverage in the various systems around the world. Results: The study identified 279 publications, and after removing duplicates and screening for eligibility, 10 were included in the study. The results show that various financing models have been proposed, including subscription-based payment models, outcome-based payment models, and amortization strategies. However, several barriers to implementing these models were identified, such as deficiencies in informatics systems for data collection, changes in laws or regulations, the lack of accessible clinical endpoints and administrative costs. Conclusion: This scoping review provides an overview of financing strategies for gene therapies. Gene therapies can cure rare or previously intractable diseases, but their high cost can make access difficult. Publishing experiences with these models can help evaluate their use and gather more evidence for their effectiveness.
dc.description.versionPublicada
dc.identifier.citationOssandon, H., Armijo, N., Vargas, C., Repetto, G. M., & Espinoza, M. A. (2024). Challenges for gene therapy in the financial sustainability of health systems: a scoping review. Orphanet journal of rare diseases, 19(1), 243. https://doi.org/10.1186/s13023-024-03249-z
dc.identifier.doihttps://doi.org/10.1186/s13023-024-03249-z
dc.identifier.urihttps://hdl.handle.net/11447/9150
dc.language.isoen
dc.subjectDelivery of Health Care / economics
dc.subjectGenetic Therapy* / economics
dc.subjectHumans
dc.titleChallenges for gene therapy in the financial sustainability of health systems: a scoping review
dc.typeArticle
dcterms.accessRightsAcceso Abierto
dcterms.sourceOrphanet journal of rare diseases
dspace.entity.typePublication
relation.isAuthorOfPublication98c75303-d87e-4c17-9d27-d9d710229223
relation.isAuthorOfPublication.latestForDiscovery98c75303-d87e-4c17-9d27-d9d710229223

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Challenges for gene therapy in the financial sustainability of health systems a scoping review.pdf
Size:
1.37 MB
Format:
Adobe Portable Document Format
Description:
Texto Completo
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
347 B
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services